These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2776702)

  • 21. [Complete response in a case of unresectable gastric cancer treated by combined chemoimmunotherapy of MMC, 5-FU and OK-432].
    Tsuji Y; Suematsu T; Kawabata S; Kodama I; Koufuji K; Aoyagi K; Tanaka T; Maruiwa M; Ohta J; Kumegawa H
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2045-8. PubMed ID: 8085856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT].
    Sinmyo K; Hosoi H; Suwa H; Kitagawa M; Yamaguchi K; Susaki H
    Gan To Kagaku Ryoho; 1989 May; 16(5):2051-7. PubMed ID: 2499267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intratumor injection of OK-432-stimulated peripheral blood mononuclear cells: a significance of mononuclear cell-producing tumor inhibitory factor induced by OK-432].
    Mizoguchi T; Katano M; Yamamoto H; Hisatsugu T
    Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):794. PubMed ID: 3627102
    [No Abstract]   [Full Text] [Related]  

  • 25. [The combination therapy of local administration of OK-432 and radiation for 2 cases of lower bile duct carcinoma].
    Mukai M; Morita S; Tsunemoto H
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):617-21. PubMed ID: 2768973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraperitoneal administration of the biological response modifier OK-432 and peritoneal recurrence following gastrectomy.
    Tsujitani S; Abe Y; Korenaga D; Saitoh A; Watanabe A; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):498-502. PubMed ID: 2253926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intraoperative intraperitoneal administration of mitomycin C and OK-432 for peritoneal dissemination of gastric cancer].
    Sugiyama Y; Yoshida A; Takao H; Kunieda K; Miya K; Azuma S; Tanemura H; Furuta T; Saji S
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1592-5. PubMed ID: 2117890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic therapy in patients with inoperable early gastric cancer.
    Haruma K; Sumii K; Inoue K; Teshima H; Kajiyama G
    Am J Gastroenterol; 1990 May; 85(5):522-6. PubMed ID: 2337054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic intratumoral injection of OK-432 and Langerhans' cells in patients with gastric carcinoma.
    Tsujitani S; Okamura T; Baba H; Korenaga D; Haraguchi M; Sugimachi K
    Cancer; 1988 May; 61(9):1749-53. PubMed ID: 3281742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Local immunotherapy of breast cancer: a case of advanced breast cancer improved by combined local injection therapy with OK-432 and rIL-2].
    Fujimori M; Sugenoya A; Kobayashi S; Masuda H; Komatsu M; Takahashi S; Shimizu T; Tsuchiya S; Iida F
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2760-3. PubMed ID: 2551219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An intractable gastric cancer showing an extremely effective response to immunochemotherapy].
    Takashima S; Komaki H; Yokota H; Kiriyama M; Kinami Y
    Gan No Rinsho; 1988 Jul; 34(8):1031-5. PubMed ID: 3136258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
    Yamamura Y; Yasue M; Kito T; Nakazato H; Yamada E
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1603-9. PubMed ID: 6409009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF).
    Katano M; Mizoguchi T; Yamamoto H; Nakamura M; Matsuo T; Hisatugu T; Kisu T; Yamaoka K; Tokunaga O
    Jpn J Surg; 1990 Jan; 20(1):76-82. PubMed ID: 2304290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intraperitoneal cavity injection of OK-432 with fresh human serum in a case of carcinomatous peritonitis--determination on the complement-derived chemotactic factor].
    Kato H; Kondo Y; Tanigawa M; Kin R; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3251-5. PubMed ID: 3777961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intraperitoneal administration of OK-432 and rIL-2 in a case of peritonitis carcinomatosa with chronic renal failure].
    Kanaoka Y; Umesaki N; Kawabata M; Tsuda H; Sugawa T
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):1027-31. PubMed ID: 2391442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer].
    Nio Y; Tobe T
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1436-8. PubMed ID: 2586435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.